Back to Results
First PageMeta Content
Gut flora / Antiprotozoal agents / Gram-negative bacteria / Metronidazole / Pfizer / Sanofi / Anaerobic infection / Helicobacter pylori / Clostridium difficile / Bacteria / Microbiology / Medicine


Rationale for the EUCAST clinical breakpoints
Add to Reading List

Document Date: 2010-02-23 05:33:56

Open Document

File Size: 148,17 KB

Share Result on Facebook
UPDATE